AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24092978
Drug: Rivastigmine 18
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rivastigmine 18 mg patch with domperidone 30 mg (RWD)
Trial: 21466595
Drug: Risedronate (RIS)
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Risedronate (RIS) 35 mg/week plus calcium 1000 mg/day and vitamin D(3) 800 IU/day
Trial: 21466595
Drug: Calcium 1000
RxNorm normalized name: RITE AID Calcium 1000mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium 1000 mg/day and vitamin D(3) 800 IU/day
Trial: 10853164
Drug: Epidural corticosteroid
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural corticosteroid injection (100 mg methylprednisolone in 10 mL bupivacaine 0.25%)
Trial: 10853164
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no epidural corticosteroid injection)
Trial: 1556404
Drug: 1,200 mg
RxNorm normalized name: lecithin 1,200 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,200 mg Mg(OH)2
Trial: 1556404
Drug: 2,400 mg
RxNorm normalized name: pancreatin/lipase/protease/amy 2,400 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2,400 mg Mg(OH)2
Trial: 1556404
Drug: 3,600 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3,600 mg Mg(OH)2
Trial: 1556404
Drug: Mg(OH)2 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mg(OH)2 (all doses)
Trial: 30321900
Drug: Classical Massage
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Classical Massage Therapy (KMT)
Trial: 30321900
Drug: Acupuncture Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture Therapy (AKU)
Trial: 12215984
Drug: Ropivacaine 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 5.0 mg/mL
Trial: 23222363
Drug: Ropivacaine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 7.5 mg/mL
Trial: 10412335
Drug: Environmental controls
RxNorm normalized name: ZINC OXIDE 225 mg in 100 mL TOPICAL CREAM [ENVIRONMENTAL DEFENSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Environmental controls (wrapping mattress with vinyl cover, washing bedding with hot water every two weeks, removal of soft furniture, wet cleaning bedroom floor daily)
Trial: 6464626
Drug: Postoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative treatment without nasogastric tubes
Trial: 19024521
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg twice daily for 7 days
Trial: 9272808
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with a history of injection drug use (IDU)
Trial: 9272808
Drug: Patients acknowledging
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients acknowledging continued drug use
Trial: 9272808
Drug: Patients denying
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients denying any recent drug use
Trial: 7878558
Drug: 2.0 mg
RxNorm normalized name: LORAZEPAM 2.0 mg in 1 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 mg terbutaline from a pressurised metered dose inhaler (MDI) with spacer (4 x 0.25 mg doses)
Trial: 2975458
Drug: Incremental doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incremental doses of synthetic atrial natriuretic peptide in sodium-replete dogs
Trial: 2975458
Drug: Incremental doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incremental doses of synthetic atrial natriuretic peptide in sodium-depleted dogs
Trial: 24535888
Drug: Fexinidazole single
RxNorm normalized name: fexinidazole
DrugBank: Fexinidazole (DB12265)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fexinidazole single dose (100 to 3,600 mg)
Trial: 21823199
Drug: Group Cognitive-Behavioural
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group Cognitive-Behavioural Therapy (CBT)
Trial: 17573387
Drug: 900 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg/day UDCA
Trial: 2547680
Drug: Enalapril, 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril, 0.5 mg.kg‐1.day‐1 for 4 weeks
Trial: 1095108
Drug: Intra-arterial infusion
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial infusion of Solcoseryl
Trial: 29522089
Drug: Artemisinin-based combination
RxNorm normalized name: artemisinin
DrugBank: Artemisinin (DB13132)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artemisinin-based combination therapy
Trial: 10023943
Drug: Bisoprolol 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol 1.25 mg daily, increased to a maximum of 10 mg per day
Trial: 2110430
Drug: Insulin and
RxNorm normalized name: Isophane insulin and porcine regular insulin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin and hydroxychloroquine (n = 11)
Trial: 21869712
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide (TA) 40 mg
Trial: 27856801
Drug: Methylprednisolone acetate
RxNorm normalized name: methylprednisolone acetate
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone acetate (MA) 40 mg
Trial: 25890808
Drug: Mobile-bearing TKA
RxNorm normalized name: Chamaemelum nobile extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mobile-bearing TKA implant
Trial: 25890808
Drug: Fixed-bearing TKA
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fixed-bearing TKA implant
Trial: 23376864
Drug: Sildenafil, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil, 50 to 100 mg as needed
Trial: 21795740
Drug: Partially hydrogenated
RxNorm normalized name: SOY OIL,PARTIALLY HYDROGENATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partially hydrogenated soybean oil (15.7 g/day IP‐TFA)
Trial: 18003511
Drug: 2 ng/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ng/ml effect compartment controlled remifentanil
Trial: 11465304
Drug: Tapered discontinuation
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tapered discontinuation of cyclosporin microemulsion
Trial: 11465304
Drug: Abrupt discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abrupt discontinuation of cyclosporin microemulsion
Trial: 4063085
Drug: Indoor therapy
RxNorm normalized name: Cleartime Indoor & Outdoor Allergies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indoor therapy exercises with elements of games (B2 subgroup)
Trial: 4063085
Drug: Indoor therapy
RxNorm normalized name: Cleartime Indoor & Outdoor Allergies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indoor therapy exercises with 5.2 mg of nitrong 1 hour prior to PT (B3 subgroup)
Trial: 29558650
Drug: Cognitive-behavioral group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral group therapy (CBGT)
Trial: 29195836
Drug: Switch to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switch to monotherapy from two non‐clozapine oral antipsychotics
Trial: 29195836
Drug: Stay on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stay on polypharmacy with two non‐clozapine oral antipsychotics
Trial: 29195836
Drug: Switch to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switch to monotherapy from combinations involving clozapine or an injectable antipsychotic
Trial: 17627166
Drug: Cefazolin 1
RxNorm normalized name: cefazolin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin 1 g (first-generation cephalosporin)
Trial: 17627166
Drug: Cefuroxime 750
RxNorm normalized name: cefuroxime 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime 750 mg (second-generation cephalosporin)
Trial: 21443601
Drug: Alitretinoin 30
RxNorm normalized name: Alitretinoin
DrugBank: Alitretinoin (DB00523)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alitretinoin 30 mg and simvastatin 40 mg
Trial: 21443601
Drug: Alitretinoin 30
RxNorm normalized name: Alitretinoin
DrugBank: Alitretinoin (DB00523)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alitretinoin 30 mg and ciclosporin A 300 mg
Trial: 21443601
Drug: Alitretinoin 30
RxNorm normalized name: Alitretinoin
DrugBank: Alitretinoin (DB00523)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alitretinoin 30 mg
Trial: 19347367
Drug: Zinc supplements
RxNorm normalized name: Zinc Supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplements (10 mg/day) in frequent relapsers
Trial: 3355578
Drug: 170 mg
RxNorm normalized name: mannitol 170 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 170 mg alpha‐tocopherol
Trial: 16948779
Drug: Dietary supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplementation containing melatonin, l‐tryptophan, vitamin B6, folic acid, vitamin B12, methionine and betaine for 40 days.
Trial: 16948779
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole for 40 days.
Trial: 24172641
Drug: Cryoultrasound therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryoultrasound therapy
Trial: 25470572
Drug: Methylphenidate hydrochloride
RxNorm normalized name: Methylphenidate Hydrochloride
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate hydrochloride extended-release (MPH-MLR)
Trial: 16804432
Drug: MMRV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMRV vaccine (one of 3 consistency lots)
Trial: 16804432
Drug: MMR +
RxNorm normalized name: varicella-zoster virus vaccine live (Oka-Merck) strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMR + V (administered at separate injection sites)
Trial: 12450703
Drug: MMRV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMRV vaccine
Trial: 14530872
Drug: 30 microk/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 microk/kg PEG‐rHuMGDF administered on day ‐6 followed by 10 microg/kg on days ‐5 to day 6 (n=35)
Trial: 14530872
Drug: Placebo as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo as a single dose on day ‐6 (n=9)
Trial: 14530872
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered on day ‐6 to day 6 (n=9)
Trial: 11030677
Drug: Routine speech
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine speech and language therapy
Trial: 1984187
Drug: Low-protein, low-phosphorus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein, low-phosphorus diet (0.6 g of protein per kg of ideal body weight per day, 500 to 1000 mg of phosphorus, 2000 mg of sodium)
Trial: 1984187
Drug: Control diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control diet (at least 1 g of protein per kg per day, 1000 mg of phosphorus, 2000 mg of sodium)
Trial: 29214015
Drug: Spinal manipulative
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal manipulative treatment (SMT)
Trial: 29792372
Drug: THC:CBD oromucosal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THC:CBD oromucosal spray (Sativex®)
Trial: 17760536
Drug: Quadrant-wise basic
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrant-wise basic periodontal therapy (BPT)
Trial: 8151910
Drug: SBT/CPZ monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SBT/CPZ monotherapy
Trial: 8151910
Drug: SBT/CPZ combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SBT/CPZ combined therapy
Trial: 1908584
Drug: No pill
RxNorm normalized name: Beano Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No pill
Trial: 26605240
Drug: Memantine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine plus atypical antipsychotic
Trial: 18459553
Drug: Polyethylene glycol-electrolyte
RxNorm normalized name: Polyethylene Glycol
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene glycol-electrolyte lavage solution (PEG-ELS)
Trial: 16298243
Drug: Galantamine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine (4 mg bid) for 7 days
Trial: 14624153
Drug: Interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2b daily (3 million units) plus ribavirin
Trial: 14624153
Drug: Interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2b thrice-weekly (3 million units) plus ribavirin
Trial: 10963197
Drug: sirolimus 2
RxNorm normalized name: sirolimus 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sirolimus 2 mg daily (n=284)
Trial: 10963197
Drug: sirolimus 5
RxNorm normalized name: SIROLIMUS 5 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [FYARRO]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sirolimus 5 mg daily (n=274)
Trial: 1565457
Drug: Postoperative subconjunctival
RxNorm normalized name: lincomycin
DrugBank: Lincomycin (DB01627)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative subconjunctival injections of 5-fluorouracil (5-FU)
Trial: 31812339
Drug: 268 mg
RxNorm normalized name: vitamin E 268 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 268 mg α‐T
Trial: 31812339
Drug: 526 mg
RxNorm normalized name: PhysioSol 30 MG / 37 MG / 222 MG / 526 MG / 502 MG per 100 ML Irrigation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 526 mg TRF
Trial: 29333776
Drug: L+SRP (Nd:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L+SRP (Nd: YAG laser followed by Scaling and Root Planning)
Trial: 24647388
Drug: Whole blood
RxNorm normalized name: Whole blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole blood (EDTA and heparin) stored with an icepack for 24 or 48 hours
Trial: 12710865
Drug: Memantine 10
RxNorm normalized name: Memantine 10mg Oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine 10 mg/day
Trial: 3902676
Drug: Fenquizone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenquizone (10 mg)
Trial: 1778085
Drug: Chlorthalidone (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone (25 mg)
Trial: 30027269
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (200,000 IU initial bolus followed by 100,000 IU monthly)
Trial: 26715500
Drug: Intravenous cefuroxime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cefuroxime 1.5 g (group A)
Trial: 16038473
Drug: Didanosine (ddI)
DrugBank: Didanosine (DB00900)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Didanosine (ddI) for 4 weeks in addition to current combination therapy
Trial: 12372925
Drug: Ionic X-ray
RxNorm normalized name: lactose, x-ray exposed (1000 rad)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ionic X-ray contrast agent (ioxaglate)
Trial: 12372925
Drug: Non-ionic X-ray
RxNorm normalized name: lactose, x-ray exposed (1000 rad)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ionic X-ray contrast agent (iopromide)
Trial: 1951234
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg bid famotidine
Trial: 7038565
Drug: Metered aerosol
RxNorm normalized name: nitroglycerin
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered aerosol dose of fenoterol
Trial: 7038565
Drug: Aerosol inhalation
RxNorm normalized name: Albuterol Inhalation Aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosol inhalation
Trial: 7038565
Drug: Powder inhalation
RxNorm normalized name: Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powder inhalation
Trial: 26492879
Drug: Basic Body
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic Body Awareness Therapy
Trial: 24163324
Drug: Carbon nanoparticle
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbon nanoparticle suspension injection
Trial: 21196444
Drug: Intracoronary adenosine
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary adenosine 4 mg
Trial: 19644189
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of valacyclovir daily for 6 months
Trial: 19644189
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of valacyclovir daily for 12 months
Trial: 19644189
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of valacyclovir daily for 24 months
Trial: 19644189
Drug: Topical antiseptics
RxNorm normalized name: Listerine Antiseptic
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical antiseptics (control group)
Trial: 2015724
Drug: 1 gm
RxNorm normalized name: Ifex 1 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 gm acetaminophen
Trial: 7235205
Drug: Microcrystalline theophylline
RxNorm normalized name: Microcrystalline Cellulose
DrugBank: Microcrystalline cellulose (DB14158)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microcrystalline theophylline tablet (Nuelin)
Trial: 28426104
Drug: Amrubicin (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amrubicin (35 mg/m2 on days 1-3 every 3 weeks)
Trial: 28341108
Drug: Docetaxel (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (60 mg/m2 on day 1 every 3 weeks)
Trial: 19108379
Drug: Lugua polypeptide
RxNorm normalized name: Heme iron polypeptide
DrugBank: Heme iron polypeptide (DB11067)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lugua polypeptide injection (16 mg per day for 2 weeks)
Trial: 19108379
Drug: Celecoxib (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (200 mg twice a day for 2 weeks)
Trial: 15608809
Drug: Green Prescription
RxNorm normalized name: acid green 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green Prescription physical activity counselling programme (verbal advice and written exercise prescription with telephone follow-up)
Trial: 10517718
Drug: Unconventional therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unconventional therapies
Trial: 6169671
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of human leukocyte interferon (HLI) ointment (4,000 units/g) for 4 weeks
Trial: 6169671
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of human leukocyte interferon (HLI) in the form of powder and solution
Trial: 6169671
Drug: Combined local
RxNorm normalized name: Local hemostatic combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined local and general therapy
Trial: 31841496
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of RFA with verapamil and 5-FU
Trial: 31841496
Drug: RFA as
RxNorm normalized name: Rfaudraksha resin
DrugBank: Acacia (DB10451)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RFA as monotherapy or in combination with chemotherapy
Trial: 24602923
Drug: Simeprevir (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simeprevir (150 mg, once daily) and peg-interferon α-2a and ribavirin (PR)
Trial: 15914936
Drug: ICD treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICD treatment
Trial: 16267706
Drug: Postoperative radio-chemotherapy
RxNorm normalized name: Valerianae radix
DrugBank: Valerian (DB13196)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative radio-chemotherapy
Trial: 16267706
Drug: No postoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No postoperative therapy
Trial: 10395859
Drug: 3.5% gel
RxNorm normalized name: NONOXYNOL-9 3.5% GEL,VAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5% gel (Advantage-24)
Trial: 7759462
Drug: Midaglizole (MID)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midaglizole (MID) 200 mg pre- and post-treatment
Trial: 7759462
Drug: Midaglizole (MID)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midaglizole (MID) 200 mg pretreatment
Trial: 7759462
Drug: Midaglizole (MID)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midaglizole (MID) 200 mg posttreatment
Trial: 31975265
Drug: Compliant antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compliant antibiotics dosing
Trial: 14996523
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide via pressurized metered-dose inhaler